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Abstract
Models of electrical activation and recovery in cardiac cells and tis-
sue have become valuable research tools, and are beginning to be used in
safety critical applications including guidance for clinical procedures and
for drug safety assessment. As a consequence there is an urgent need for a
more detailed and quantitative understanding of the ways that uncertainty
and variability influence model predictions. In this paper we review the
sources of uncertainty in these models at different spatial scales, discuss
how uncertainties are communicated across scales, and begin to assess
their relative importance. We conclude by highlighting important chal-
lenges that continue to face the cardiac modelling community, identifying
open questions, and making recommendations for future studies.
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1 Introduction
Mechanical contraction of the heart is initiated and synchronised by a wave
of electrical activation that originates in the natural pacemaker in the right
atrium and propagates through the atria and into the ventricles. An abnormal
sequence of electrical activation and recovery in the heart results in a cardiac
arrhythmia, which may require urgent medical intervention. Understanding the
mechanisms that initiate and sustain cardiac arrhythmias is a central question
in cardiac electrophysiology because there are implications for the design and
guidance of clinical interventions as well as for understanding the mechanisms
of drug action.
Mathematical and computational models of the heart can provide a detailed
and quantitative description of the electrical activation and recovery of cells and
tissue, as well as the associated changes in intracellular Ca2+ concentration that
initiate contraction [1]. These models have been widely used as research tools,
but there is a direction of travel towards safety critical applications that include
drug safety testing [2] and guidance for clinical interventions [3].
Multi-scale electrophysiology models integrate models at the cell, tissue, and
whole organ scale. There are exciting opportunities for the adoption of multi-
scale cardiac models in a predictive capacity, but these will require a much
more rigorous assessment of model credibility and confidence in predictions [4]
as part of a regulatory process that takes into account validation, verification
and uncertainty quantification of biomedical models [5].
This paper contributes to this process by undertaking an audit of the sources
of uncertainty in multi-scale and personalised models of cardiac electrophysiol-
ogy. Our aims are to document the uncertainties associated with cardiac models
at different scales, to assess their relative importance, and to make recommenda-
tions for best practice. We concentrate on models of electrophysiology in order
to keep the analysis tractable, but we have included references to relevant and
related work on uncertainty quantification in models of cardiac mechanics and
cardiovascular flow. Our main focus is on the effects of experimental errors, un-
certainties, and natural variability on model calibration; discrepancies between
model and reality arising from modelling assumptions and simplifications; un-
certainties arising from the choice of modelling framework; and the challenges
presented by the clinical setting.
2 Background
2.1 Cardiac electrophysiology models at different scales
During each normal heart beat cardiac cells undergo an action potential, which
is a sequence of electrical activation and recovery. In the resting state, the cell
membrane is electrically polarised. There is a potential difference of around
−90 mV across the cell membrane, with intracellular space maintained at a
lower potential than extracellular space by differences in ion concentrations.
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During activation, the potential difference depolarises to around +30 mV as
a result of conventional current carried by Na+ and Ca2+ ions that flow into
the cell. The cell then repolarises back to −90 mV as a result of currents that
flow out of the cell, mainly carried by K+ ions. Following activation, the cell
remains in a refractory state until recovery is complete.
Inward and outward currents flow through ion channels, pumps, and ex-
changers in the cell membrane. Their behaviour can be represented in math-
ematical models, where ionic currents are described as a set of coupled and
nonlinear ordinary differential equations (ODEs) [6]. Biophysically detailed cell
models can also represent the storage, sequestration, release and uptake of in-
tracellular Ca+ as an additional set of ODEs.
Cardiac cells (myocytes) are typically rod-shaped, and tend to be aligned
with their neighbours to form fibres and sheets [7]. Myocytes are electrically
coupled through gap junctions located predominantly at their ends, and so
action potential propagation is faster along fibres than across fibres, with an
intermediate propagation speed within sheets. At the cell scale, propagation of
the action potential from one cell to its neighbours is a discrete process [8], but
at the macroscopic scale normal cardiac tissue behaves as a continuum. The
bidomain model of cardiac tissue represents tissue as a continuum composed
of intracellular and extracellular domains, and a generalisation of Ohm’s law
leads to a system of partial differential equations (PDEs) with the cell model
included as a reaction term [9]. The bidomain model incorporates anisotropic
propagation along fibres as conductivity tensors in both intracellular and extra-
cellular domains. If the conductivity tensors for both domains are proportional,
which corresponds to identical anistropy ratios, then the bidomain equations can
be simplified to the monodomain equation, which is a single reaction-diffusion
PDE.
Cardiac tissue models are typically solved on a computational mesh using
finite difference, finite element, or finite volume methods. The mesh may be
an idealised geometry, such as a 2D sheet, or an anatomically detailed model
obtained from medical images. These solutions will involve choices of model
parameters, such as tissue conductivities, as well as solver parameters, such as
times steps and space steps [10].
2.2 Features of interest
Cardiac cell and tissue model outputs include features that not only depend on
model parameters and structure, but also influence model behaviour. These are
illustrated in Figure 1 and include:
• Action potential shape and duration. The action potential upstroke
determines propagation speed in tissue, and action potential duration
(APD) is related to the refractory period, which determines the rate at
which the cell can be repeatedly activated.
• Spontaneous activity. Some cells are able to generate spontaneous ac-
tion potentials. This is essential for cells in the heart’s natural pacemaker
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where the rate of spontaneous depolarisation is an important feature, but
in other regions of the heart spontaneous early or delayed afterdepolari-
sations (EADs and DADs) can result in arrhythmias.
• Dynamic behaviour. APD and propagation speed are rate-dependent
properties of cardiac cells and tissue, and under some conditions cells and
tissue exhibit alternans, where APD alternates from one beat to the next.
• Activation and recovery sequence. A consistent electrical activation
sequence from one beat to the next is important for efficient mechanical
contraction. Abnormal activation and recovery sequences arising from
tissue pathology or EAD/DADs can disrupt contraction, and also indicate
heightened vulnerability to arrhythmia.
• Arrhythmia vulnerability. Re-entry is a type of arrhythmia where
an action potential continually propagates into recovering tissue, and it
can be initiated by a premature stimulus (for example from a DAD) with
particular strength and timing. Vulnerability can be quantified from the
range of stimulus strength and timing that results in re-entry.
• Arrhythmia stability. Once initiated, re-entry can remain stable with
a single rotating action potential, or may break up into multiple waves of
activation.
2.3 Uncertainty and variability
A cardiac or cardiovascular model is a quantitative representation of a real sys-
tem. Since models embed assumptions and simplifications, they are necessarily
an incomplete representation, and so their outputs and behaviours will differ
from those of the real system. Additional differences will arise from the func-
tional form of the model, the precision with which model parameters are known,
the choice of initial and boundary conditions, and errors arising from the nu-
merical solution scheme that is selected. Physiological systems are inherently
variable, for example cardiac action potentials vary from cell to cell and from
beat to beat in the same cell [13, 14], and so further differences between the
model and the real system will result from natural variability. This may be
evident as model parameters that are described by a distribution instead of a
single number. Uncertainty quantification (UQ) provides a conceptual frame-
work within which uncertainty and variability can be characterised [15, 16], and
the application of these ideas to cardiac models is an area of emerging impor-
tance [4, 17, 18, 19, 20]. However, there is sometimes confusion about what is
meant by uncertainty, variability, sensitivity and error, and so next we discuss
and clarify these terms.
Uncertainty is associated with a lack of information, and uncertainties are
often categorised as either epistemic or aleatory. Epistemic uncertainties result
from a lack of knowledge about a system, and can in principle be reduced. For
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Figure 1: Cardiac electrophysiology models: Action potentials (a) and
action potential duration restitution (b) produced by a model of rabbit ventric-
ular cell electrophysiology [11] paced at a cycle length of 300 ms, showing the
effects of halving the transient outward current Ito, and doubling the rapidly
inactivating K+ current IKr. Snapshots of epicardial electrical potential from
simulations in a rabbit ventricle model with a phenomenological cell model [12],
showing activation following pacing at the apex (c), followed by unstable re-
entry initiated by a premature stimulus (d). Red regions are activated, blue
regions recovered, and arrows show direction of action potential propagation.
example one type of epistemic uncertainty in a cell model could be discrepancy
between the model and real system arising from an ion current that is neglected
or incorrectly formulated in the model. This uncertainty could in principle
be reduced by performing more experiments and/or developing a better model
[21]. Aleatory uncertainties result from random variation in the system, and are
considered to be irreducible. In most cases, aleatory uncertainty and variability
can be considered interchangeable.
Variability in cardiac models normally refers to the multiple values that a
model parameter can have at different locations or times. This natural variabil-
ity is inherent in biological systems. An example is the intrinsic beat-to-beat
fluctuation of action potential duration (APD) in a single cell and extrinsic
cell-to-cell differences in APD [13].
Uncertainty analysis and sensitivity analysis are related but distinct ideas
[17]. Uncertainty analysis is normally used to investigate how uncertainty in
model parameters affects model outputs [22]. Sensitivity analysis naturally fol-
lows uncertainty analysis as it gauges how variability in model outputs can be
related qualitatively or quantitatively to contributions from changes in model
parameters or other inputs [23, 24].
Several techniques have been developed for sampling-based approaches used
to perform uncertainty analysis namely, Monte Carlo (MC) and Latin hyper-
cube sampling (LHS) methods [25, 26, 27, 28, 29]. MC methods involve multiple
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model evaluations using random numbers to sample from probability distribu-
tions of uncertain inputs. Sampling is guided by the specification of a probability
density function, depending on a priori information. The results of these eval-
uations can be then used to characterise uncertainties in model responses and
perform sensitivity analysis [30, 31, 32]. LHS methods use stratified sampling
without replacement, where the random parameter distributions are divided
into sub-intervals with equal probability. LHS is a space-filling technique that
optimises the coverage of a high dimensional input space. LHS allows for un-
biased measure of the average model output, with the advantage that it requires
fewer samples when compared with simple random sampling to achieve the same
coverage. Several developments that explain how to implement LHS methods
in different scientific applications can be found in [33, 34, 35, 27].
Normally, uncertainties are considered to affect the output of a computa-
tional model, but they should not be termed errors because they are physical
and inherent in the model itself. Errors can be defined as an a priori estimate
of deficiencies in the models or the algorithms employed to solve them. Errors
are mathematical in nature and arise when translating the system physics into
approximate numerical algorithms and computational code. Inaccuracies, in-
trinsic to the discretisation process, are introduced in this step giving rise to
numerical errors. These errors can be controlled and reduced to a smaller level
if the numerical methods and algorithms used are selected carefully. Acknowl-
edged error is related to the finite precision arithmetic that is used to perform
the calculations (round-off) and convergence accuracy. Unacknowledged error
is related to coding mistakes during implementation, and can lead to differences
between codes that implement identical models [36].
3 Cell scale models
Cardiac electrophysiology models at the cellular scale reconstruct the action
potential (AP) and Ca2+ transient of cardiac myocytes, facilitate understand-
ing of mechanisms, and are represented typically using a system of non-linear,
coupled, and often stiff ODEs [6]. Following the initial work by Noble in
1962 [37], tremendous progress has been made resulting in the development
of numerous cell models for different species and different regions of the heart
[6, 38, 39]. Depending on the purpose and context of use, these cell models are
often constructed using biophysically-detailed, simplified or phenomenological
frameworks [6, 38]. Whilst biophysically-detailed cell models integrate explicit
descriptions of transmembrane ion channels, transporters and exchangers and
intracellular Ca2+ handling, simplified models are generated by reducing the
number of ODEs in biophysically-detailed models. In simplified models, in-
tracellular Ca2+ dynamics are frequently described using a common pool [40],
compartmentalized [41] or spatially-detailed representation [42]. On the other
hand, phenomenological models are designed for large scale tissue simulations
and utilise a minimal number of ODEs to reproduce key aspects of global dy-
namics of the transmembrane voltage at low computational cost [6], without
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accounting for details of ion currents or Ca2+ handling.
Transmembrane voltage in cardiac cell models is generally described by a
Hodgkin and Huxley type electrical circuit model, in which the gating behaviors
of ionic currents are simulated using memory-less Markov chain-type models,
and transporters and exchangers are simplified as time-independent processes
[6]. Intracellular Ca2+ release from the ryanodine receptors (RyR) is mod-
elled by multiple-state Markov models or ODEs. Although each component
of these models is calibrated against data from carefully designed experiments,
uncertainties can arise from discrepancy between the model and the real sys-
tem, calibration, and choice of an appropriate model. We discuss each of these
sources in turn.
3.1 Model discrepancy, calibration, and identifiability
Biophysically-detailed cell models combine models of subcellular processes and
so model discrepancy (sometimes called structural uncertainty) in each compo-
nent is propagated to the cellular level. This is exemplified by the number and
topology of states in a Markov model of ion currents and current models of in-
tracellular Ca2+ recycling [4], as well as simplifications to the models of intracel-
lular Ca2+ buffers and post-translational modifications. Typically, models are
calibrated before being used for predicting unseen scenarios, sometimes referred
as the context of use. One aspect of model calibration is the process of tuning
model parameters to minimise the difference between observations and model
simulations. However even for cell-scale models this is not a trivial task [43].
Model parameters describing channel conductances and flux rates are generally
further tuned to simultaneously calibrate the model output often to important
electrophysiological biomarkers such as APD, resting membrane potential, up-
stroke velocity, and systolic and diastolic Ca2+ concentrations. These data are
obtained from multiple experimental protocols and conditions (e.g., different
pacing rates, extracellular ion concentrations).
Identifiability can be an important consideration when calibrating a model.
An identifiable model has a unique set of parameters for which the model sim-
ulation matches a particular experiment [44]. Non-identifiability can indicate
that the model structure is incorrect, or that the experimental observations do
not allow the parameters to be identified. The activation and recovery of real
cardiac cells is very robust, and is based on many redundant components. This
redundancy can make the task of model calibration ill-posed. For instance, in
[45] a model of the human ventricular action potential was adjusted to repro-
duce specific experimental observations. By calibrating only to the shape of the
action potential, hundreds of models, each with a different parameter set, could
reproduce the data and so the model was not identifiable. Conversely, a wide
range of action potentials can be produced by variations in model parameters
[46]. Measurements of action potentials alone may therefore be necessary but
not sufficient to calibrate a cell model correctly [47, 48]. In [45], it was found
that by using both the action potential shape and the transmembrane resistance
profile as two different objective functions, the models were forced to solve a
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trade-off and the possible candidates that could reproduce both observations
decreased to just a few. Assessing whether we have sufficient experimental in-
formation that allows us to infer all of the parameters therefore becomes a task
of primary importance [49, 21, 48], and recent review discusses these issues in
detail [50].
3.2 An abundance of cell models
Cardiac cell models have been developed to represent myocytes from many
different species and different parts of the heart. Many of these models have
been encoded and curated within the CellML framework (see https://models.
physiomeproject.org/electrophysiology). In addition, different research
groups have independently developed cardiac models that represent the same
species and region of the heart, usually based on different experimental data sets
[51, 52, 53]. One might expect these models to be similar. However they usually
differ in many aspects, and may behave very differently. Selecting an appropriate
model for a particular task therefore becomes important, and highlights the
limitations of cardiac electrophysiology models. For example Fig. 2 illustrates
three models of the human ventricular action potential each with a different
time course of action potential and principal currents.
In [51], six different models of human ventricular myocytes were compared.
They were all based on systems of ODEs, but ranged from a phenomenological
model with only four state variables, to a biophysically detailed model with 67
state variables. The differences in complexity reflect the intended context of
use of these models. A more detailed context of use will usually require a more
detailed model, but complexity often has to be tensioned against computational
cost. For example, a model used to investigate the whole-cell consequences of a
gene mutation or drug action will require a detailed Markov chain description
of ion channel states, which may be computationally intensive when embedded
in a tissue scale model. On the other hand, cell models that use the Hodgkin-
Huxley (HH) formalism to describe ion channel kinetics would be appropriate
for a study of arrhythmia dynamics, and would be less computationally inten-
sive. We could think of a hierarchy of models, where detailed models should be
able to reproduce some basic phenomena as precisely as the most simple model
developed for this task. However this is not currently the case [51]. There are
many possible reasons for this observation, and we describe three of them below.
First, the different models compared in [51] were developed using different
experimental datasets, which partially explains the reason for their lack of con-
sistency. Second, in [52], a comparison was carried out between two human
atrial models that were based on the same set of experimental data available
at the time. The models have similar complexity, were both based on the HH
formalism, and yet behave differently. After a careful analysis, the lack of con-
sistency was attributed to different structure in the models of intracellular Ca2+
storage and release. In the absence of Ca2+ data for human atrial cells, two
different and previously developed mammalian models of Ca2+ handling were
incorporated into the cell models. These modulate transmembrane ion currents
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in different ways, resulting in uncertainty arising from different model discrep-
ancies. A third source of inconsistency between models of the same species
and the same region of the heart is natural variability. It is well known that
neighbouring cells can behave similarly when diffusively coupled in tissue, but
differently when isolated, which is due to electrotonic effects [54]. In addition,
cells used in experiments can come from different hearts, of different ages, gen-
der, and health condition, with different genotype and phenotype. However,
most of the models in cardiac electrophysiology today do not take account of
natural variability, which is often partially reported in experimental work using
basic statistical measures such as mean and variance.
Uncertainties, variability, and errors in experimental observations can also
come from experimental design, instrumentation, experimental conditions, ex-
perimental protocols, and can even be influenced by the experimentalist in
charge of the experiment. Therefore, methods such as history matching (HM)
and MCMC are promising for model calibration because they take explicit ac-
count of uncertainty and variability in observations. For instance, HM can define
feasible regions of the model parameters that produce results within the exper-
imental variability [55]. MCMC methods search for probability distributions
for all the parameters that again can produce results within the experimental
variability, but are more computationally demanding [56]. Therefore, instead of
adjusting a single model to the experimental data, MCMC and HM can gener-
ate a population of models, where each model can reproduce the experiments
within a margin given by the total variability.
Figure 2: Uncertainties in cell scale models arising from model choice
showing different action potential shapes, calcium transients, APD restitution,
and time course of principal ionic currents produced by different human models
for ventricular myocytes.
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3.3 Uncertainty in cell scale models
Developing accurate mathematical models of cardiac cell electrophysiology re-
quires integration of multiple data sets from various in-vivo/vitro sources into
a reliable biophysical computational platform. Although this methodology is
routinely applied, as demonstrated by the increasing number of studies which
use or extend previously developed cardiac cellular models [57, 58], there are
major challenges in increasing the prediction capabilities. A meta-analysis of
two human ventricular cell models has shown that although both models aim to
represent the same physiological system, the sources of parameter values from
different species and cell types, as well as the function of equivalent components
were significantly different [59]. Experimental measurements may be made at
room temperature, and although model parameters are sometimes adjusted to
compensate for temperature differences, these adjustments might lead to further
uncertainty [60].
All of these uncertainties can affect features of interest in cardiac electro-
physiology models. Uncertainty and variability in model parameters influence
the shape and duration of both the action potential and the Ca2+ transient,
as well as rate-dependent dynamical behaviours including APD restitution and
the presence of alternans [52]. Even in a single cell model, wide variations in
parameters can produce enormous variation in the action potential [46]. Cer-
tain regions in parameter space can also produce spontaneous depolarisation of
cell models [61, 62]. The choice of cell model for a particular application is an
important source of uncertainty, and discrepancy between the model and the
real system may make the greatest contribution to output uncertainty (Fig 2).
In the following section we consider how these cell-scale uncertainties combine
with uncertainties associated with tissue scale models.
4 Generic tissue scale models
Models of action potential propagation in cardiac tissue reconstruct the elec-
trical coupling of individual myocytes through gap junctions. Generic tissue
models implement models of action potential propagation, where the tissue ge-
ometry is configured to answer a specific research question rather than to repre-
sent a particular individual. The main context of use for generic tissue models is
as research tools for understanding integrative physiological mechanisms. Per-
sonalised models aim to reconstruct electrical activation in an individual, and
we cover these in section 5. Uncertainty in generic tissue models arise from the
choice of tissue geometry, modelling framework, initial conditions, and boundary
conditions. We consider these in turn below.
4.1 Tissue geometry
Individual myocytes are rod-shaped, and tend to be aligned in fibres. Propa-
gation in cardiac tissue is typically anisotropic because action potential prop-
agation is faster along fibres than transverse to them. In ventricular tissue
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the fibre structure can be well characterised [63], although this approach does
not explicitly consider fibre branching. Furthermore, fibres are also arranged
in sheets, and the orthotropic behaviour arising from preferential propagation
within sheet planes is less well understood [64].
Generic cardiac tissue models can be configured as a 1D fibre, a 2D sheet,
a 2D sheet with anatomical detail such as a short axis slice through the ventri-
cles, a 2D surface representing generic atrial anatomy, a 3D tissue block with
or without anisotropy/orthotropy (See for example Figure 3), a 3D ellipsoid
or idealised biventricular model, or a 3D atrial or ventricular model based on
generic anatomy. Fibre and sheet fields can be incorporated into anatomical
models using rule-based methods that are grounded in experimental observa-
tions [63, 65, 66].
Simplified geometries enable mechanisms to be simulated and investigated
without the confounding effects of anatomical detail, but there is associated
model discrepancy because these geometries may not represent the fine detail of
real tissue. For example there is a tendency for re-entrant drivers in AF to an-
chor in regions characterised by a large atrial wall thickness gradient [67, 68], and
this is an observation that would be missed by simplified 2D atrial geometries.
The importance of model discrepancy in this context depends on the research
question, and so a simplified geometry should be chosen with consideration of
the assumptions and limitations, and these should be carefully documented.
4.2 Modelling framework
A homogenisation approach to models of coupled cells leads to a set of one or
more partial differential equations (PDEs) that describe action potential propa-
gation, where the cell models described above appear as a reaction term [69, 9].
This is a convenient simplification that enables efficient numerical solutions on
a mesh.
Cardiac tissue can be represented as a bidomain or a monodomain. For
anisotropic tissue, if the ratio of longitudinal and transverse conductivity is the
same for intracellular and extracellular space, and provided no current is injected
into the extracellular space, the differences between bidomain and monodomain
simulations are minimal [70, 71]. However, use of the bidomain model is essen-
tial for the correct modelling of the response to defibrillation [72]. Errors arising
from numerical solutions of both monodomain and bidomain models are rela-
tively small, provided care is taken to ensure numerical convergence [59, 73, 74].
The homogenisation inherent in both bidomain and monodomain models
assumes that tissue can be treated as a functional syncytium. However, cardiac
tissue microstructure affects activation and recovery in real tissue, and this is
a source of model discrepancy. Important features include heterogeneity of cell
type [54], fibre and sheet architecture [64], the presence of fibrosis and small
lines of block [75, 76], and the role of the conduction system [77]. Some of these
effects are blurred by diffusive coupling in bulk tissue, but may be exposed under
pathological conditions such as the presence of fibrosis. For example, small scale
features can be important for simulating mechanisms of atrial fibrillation [78],
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and alternative approaches that preserve microstructure have been proposed
[79, 80, 81].
Fibrosis is an important aspect of microstructure. Several recent studies have
addressed the problem of representing the presence of fibroblasts, macrophages,
and their coupling [82, 83, 84, 85], but there is no consensus on the most suitable
approach. The spatial scale of patchy fibrosis varies, and different configurations
of fibrosis influence vulnerability to arrhythmias [86, 87]. Although it is known
that there are regional differences in the response of the ventricles to autonomic
stimulation [88], the distribution of nerve terminals is not well established [89].
All of these can be considered to be sources of epistemic uncertainty in generic
tissue models.
4.3 Parameter selection
A significant component of the modelling framework is the choice of model pa-
rameters including tissue conductivities, surface to volume ratio, and membrane
capacitance. Tuning these parameters enables a tissue model to be calibrated
so that it is representative of real tissue. However, these parameters depend
on the choice of cell model [9], are very difficult to measure directly [64], may
vary spatially, and estimates can vary as much as five-fold [9]. A pragmatic
approach to calibration is to adjust these parameters to reconstruct the conduc-
tion velocity or activation pattern observed in real tissue. For anisotropic and
orthotropic simulations, a further choice is the ratio of conductivities. Fig. 3
illustrates how the ratio of longitudinal and transverse conductivity, as well as
the presence of curved fibres, can influence activation, recovery, and APD in a
small tissue block. Detailed models of tissue microstructure are being used to
characterise the distributions of these parameters in normal and diseased tissue
[90], but parameter selection and choice of cell model should be considered an
important source of uncertainty in generic tissue models.
4.4 Boundary and initial conditions
For monodomain simulations, typical boundary conditions are that the gradient
of transmembrane potential difference normal to the edge or surface is zero. For
bidomain simulations, different types of boundary condition can be imposed that
can take into account the leakage of current into surrounding non-myocardial tis-
sue [9]. The effects of changing boundary conditions on arrhythmia stability are
small [71], but are important for detailed modelling of the response to pacing or
defibrillation shocks [72]. On the other hand initial conditions can be important
because of the nonlinear nature of behaviours such as VF mechanisms, where
small perturbations to initial conditions can influence the activation sequence
[4].
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4.5 Uncertainty in generic tissue scale models
Cardiac tissue models inherit all sources of uncertainty in cell scale models,
since their behaviour depends on the choice of cell model and the cell model
parameters. For example, the action potential upstroke in a cell model in-
fluences conduction velocity in tissue, which goes on to affect the activation
sequence. Both APD and APD restitution at cell scale affect the recovery se-
quence in tissue. Spontaneous depolarisation at the cell scale may be produced
by variability in model parameters, and can result in arrhythmias in tissue [91].
Diffusive coupling in tissue tends to suppress the effect of both intrinsic and
extrinsic variability in action potential shape and duration in cell scale models
[14]. Nevertheless, selection of cell model parameters can affect the behaviour
of simulated arrhythmias[92]. In particular, a cell-scale APD restitution curve
that is either steep or shows alternans can increase vulnerability to re-entry in
tissue, as well as influencing stability or re-entry [53, 52]. However, despite the
generally accepted understanding that the cell model and its parameters influ-
ence simulated electrical activation in tissue, there is not yet a comprehensive
and quantitative description of uncertainty propagation from cell to tissue scale.
A further issue is that although electrical activation in the heart acts to
initialise and synchronise mechanical contraction, the effects of mechanics are
often neglected in electrophysiology simulations and this is an important source
of model disrepancy. Mechanical contraction not only deforms the tissue, but
also changes repolarization via electrotonic effects, results in local changes in
stretch activated ion channels, and promotes wavebreak and arrhythmia in dis-
ease conditions [93, 94, 95].
5 Personalised tissue models
Personalised computational tissue models of action potential propagation differ
from generic tissue models in that the physical parameters and tissue geometry
of the system are calibrated to simulate the behaviour of one or more cham-
bers in the heart of a specific patient or animal. A personalised model can be
thought of as a special case of a generic model. The objective or context of use
for personalised electrophysiology modelling is to aid disease diagnosis, support
treatment planning or as part of a broader cohort study seeking mechanistic
insight by studying individuals. For example, one might seek to use person-
alised modelling to diagnose the origin or mechanism by which an arrhythmia
is triggered or maintained in a particular individual, or to minimise destruction
of myocardium by testing a range of potential ablation strategies [96].
In developing personalised models, care must be given to the choice of model
as well as the assumptions and simplifications made. A personalised model of
cardiac electrophysiology will use a similar modelling framework to generic tis-
sue models. However, constructing personalised models also involves calibra-
tion using specific experimental or clinical measurements. These observations
are typically noisy, sparsely collected, or incomplete due to practical or ethical
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Figure 3: Effect of anistropy ratio and curved fibres in a tissue model
Plots of (a) activation time, (b) recovery time, and (c) APD in simulations of
action potential propagation along the diagonal of a x = 20.0 × y = 7.0 × z =
3.0 mm tissue block, with straight fibres aligned along the x-axis, as described
in a benchmark study [59], or fibres that curve so that they are aligned with
the x-axis at x = 0 and are aligned with the y axis at x = 20 mm. These
measurements are shown for longitudinal:transverse anisotropy ratios of 1:4,
1:3, 1:2, and 1:1. Cell electrophysiology was described by the Ten Tusscher
2006 model, with a stimulus applied at one corner of the block. The lower panel
shows (a) activation time, (b) recovery time, and (c) APD for simulations with
anisotropy ratio of 1:3. Left panels show output for straight fibres and right
panels show output for curved fibres.
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considerations, which lead to sources of epistemic uncertainty [97].
5.1 Data acquisition for personalised models
Observations may be incorporated from a range of imaging modalities, electrical
measurements or patient records. Imaging modalities include various forms of
magnetic resonance imaging (MRI), particularly delayed gadolinium enhance-
ment for quantifying and co-localising fibrosis and scar. Electrical observations
can be used to calibrate tissue properties [98, 99], and are recorded either from
the body surface or directly from the myocardium. The body surface electro-
cardiogram (ECG) is the most common electrical measurement because it is
non-invasive. However ECGs provide only low-resolution information about the
gross electrical activity of the heart. More recently electrocardiographic imag-
ing (ECGi) offers a higher-resolution alternative and can localise information
about activation and recovery times [100]. Intra-cardiac electrical signals (elec-
trograms) are obtained from direct contact between a multi-polar diagnostic
catheter and the myocardium at or close to the endocardial surface. These are
more costly and necessarily invasive, but provide detailed and localised electro-
physiological measurements as well as positional information that can be used
to generate an endocardial mesh. Epicardial electrograms may also be obtained,
for example during open-heart surgery [101].
5.2 Mesh generation
Electroanatomical mapping data or MRI are frequently used for generating a
mesh representing the geometry of the personalised model. Fibre orientation is
not easy to characterise in-vivo and so algorithmic methods are typically used to
generate local fibre angles in personalised models [63]. The difference between
algorithmic fibre orientation and the actual fibre orientation in an individual
is likely to have a small effect on the electrical activation sequence, but could
introduce a much greater discrepancy in models that include cardiac mechanics.
Electroanatomical mapping uses catheter sensors to locate the interior surface
of a chamber and build a corresponding mesh, however uncertainties may arise
from observational uncertainty in electrode locations [97], missing regions of the
chamber and the combined motion of the thoracic cavity and heart. If MRI
is used t create a mesh, uncertainty may arise due to poor resolution of the
imaging modality and errors in the segmentation process [102]. As an example
of how mesh uncertainty affects model behaviour, Fig. 4 illustrates the effect of
uncertainty in a left atrial mesh on simulated electrical activation times [102].
Minimally-invasive cardiac MRI also contributes to observational uncer-
tainty in personalised modelling when delayed enhancement protocols are used
to identify likely regions of scar or fibrosis based on the signal intensity. In
particular challenges in the normalisation of MR signal intensity may lead to
differences in the level of intensity used to identify scar and therefore poor intra-
patient reproducibility and inter-patient consistency [103, 104].
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5.3 Model selection and parameter fitting
For personalised tissue models to be used in the clinical setting, a simplified
cell model is often used to reduce computation time [98, 105], and so model
discrepancy associated with this choice can be an important consideration. Pa-
rameter uncertainty arises directly in tissue conductivities due to our limited
understanding of how MRI intensity relates to the electroarchitecture of the
imaged substrate [106, 107, 108, 104]. This may be further compounded by
uncertainties due to co-registration of data from different imaging modalities.
Parameter uncertainty also arises due to heterogeneity of cell types, which is
challenging to measure in-vivo. This might be accounted for in the calibration
process [109].
Where electrograms are used for parameter fitting, observational uncertainty
may include errors in the electrode location which is often determined due to
a magnetic or impedance based localisation system. This will affect both the
electroanatomic geometry generated by the mapping process as well as the rela-
tive position of specific recordings [97, 110]. Electrode movement during signal
acquisition will also generate uncertainty. Processing of the signals used for
calibration will also be subject to observational uncertainty. For example, local
activation times (LATs) are regularly computed clinically and the consistent
identification of these timings is often unclear [97]. This may be due to noise
in the signal arising from poor contact or changes in impedance due to the
movement of blood around the electrode.
Model discrepancy may also become more significant for personalised mod-
elling where the pathological substrate is poorly characterised and represented
in the mathematical model. For example, the nature of conduction across diffuse
fibrosis in the atrium is poorly understood and there are outstanding challenges
in constructing the most appropriate representation in mathematical models
[82]. There are also residual uncertainties due to physical processes which are
often not accounted for, such as the lack of an explicit Purkinje network in a
ventricular model.
5.4 Uncertainty in personalised models
Personalised models inherit uncertainties from cell scale and generic tissue scale
models. The increase in model complexity in personalised tissue models leads
to a corresponding increase in the complexity and sensitivity of the output to
uncertainty and variability in the model and its parameters. Consequently ro-
bust UQ becomes more important, particularly when the context of use requires
identifying bifurcations in the solution space; for instance, when determining if
a particular treatment will terminate an arrhythmia, or not.
A key challenge is to balance the effect of uncertainties arising from these
sources against the benefits of a personalised approach. Some of the unique
considerations for UQ in personalised models in the clinical setting include ef-
fective model calibration given time constraints and limited data, how uncer-
tainties propagate across scales, and communicating uncertainties effectively so
16
that model outputs can be used as part of the decision making process. A
further challenge is to develop or adapt methods to generate consistent sam-
ples from uncertain anatomical and functional measurements. For example an
anatomical model sampled from a statistical shape model [102] should have
tissue conductivities that are sampled such that the activation sequence is con-
sistent with observations. Samples that also represent microstructure are an
additional challenge, although methods developed for geostatistical modelling
may prove to be of benefit in the future [111].
Initial condition and boundary condition uncertainties are particularly sig-
nificant for personalised modelling and are closely related to the observational
uncertainties described above. In particular, pacing locations may be uncertain
(due to observational error) but also the current amplitude injected, duration
and stimulus and contact area of pacing electrode are may not be known pre-
cisely. More subtle effects may result from the way that a re-entrant arrhythmia
is initiated. For example atrial fibrillation can be initiated by simulating burst
pacing [96, 112] or by seeding phase singularities [113], and an arrhythmia may
be simulated in a model tuned to sinus rhythm [105]. The relative importance
of these uncertainties remains an open question.For models that link to mechan-
ics and the cardiovascular system then the idea of a physiological envelope of
plausible initial and boundary conditions becomes important.
The relative importance of these uncertainties is not well characterised. Ini-
tial studies indicate that uncertainty arising from geometry and the fibrotic
substrate may be more important than uncertainties or variability in cell and
tissue electrophysiology, and this observation was consistent for both atrial and
ventricular models [114, 115, 116]. Further studies should investigate the in-
dividual and combined effects of the factors listed above on patient specific
predictions. Understanding the way that uncertainties in mesh generation com-
bine with model discrepancy to influence model credibility is an important and
as yet unanswered question.
6 Challenges, open questions and recommenda-
tions
In this paper we have reviewed the potential sources of uncertainty in multi-scale
models of cardiac electrophysiology. The list is a long one, and one response
would be that cardiac electrophysiology models are unreliable because of the
potential for uncertainties in outputs. On the other hand, the value and ef-
fectiveness of multi-scale cardiac models for explaining underlying mechanisms
and guiding interventions has been demonstrated in a range of experimental
and clinical studies [98, 99, 117, 118]. The importance of the present analysis
is therefore to highlight the potential impact of uncertainties on model outputs
and predictions, and to make recommendations for ways in which these impacts
can be mitigated. Some sources of uncertainty and variability, especially at the
cell scale, are becoming understood. Others are not well characterised. A quan-
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Figure 4: Impact of shape uncertainty on simulated activation times in
the human left atrium. Left panel shows statistical model of the human left
atrium, with the mean shape shown as solid surface and uncertainty shown as
blurring. Right hand panel shows expected value (top) and standard deviation
(bottom) of local activation time (LAT), following initial activation close to the
coronary sinus. For further details see [102].
titative and systematic assessment of their relative importance, and how they
are coupled across scales, remains an important challenge. We have highlighted
particular open questions below.
• Cell model calibration and identifiability remain key concerns for
cardiac electrophysiology models. This topic is covered in detail by an-
other paper in this volume [48] and a recent review [50]. Despite some
progress, there is a need to reflect on current experimental methods [119,
21], the way that uncertainties in experimental data are taken into account
in cell model calibration [43, 120], ways to fit models to data from indi-
vidual cells and populations [45, 49, 46], the extent to which experimental
datasets are available to the research community, and how cell models can
be constructed to facilitate uncertainty and sensitivity analysis [18]. The
importance of identifiability is yet to be explored in depth; in some situ-
ations it may be important to know that a model is uniquely identifiable,
but identifiability may be less of a concern for generic tissue models that
aim to reconstruct generic behaviours.
• Selection of an appropriate cell-scale model to answer a partic-
ular research question can be difficult because it may involve choosing
among many models, each with associated assumptions, simplifications,
and model discrepancy. Recent comparative studies (e.g. [52, 51]) are
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helpful in this regard, along with tools that enable comparison of model
components [121]. However, cell models are often selected based on per-
sonal preference or existing codes, so there is a clear need for guidelines
that can be used for rational model choice.
• Natural variability has been assessed at the cell scale [49, 46, 39, 13],
tissue scale [14] and in population studies of shape [102]. However, there
are open questions about how natural variability at these different scales
interacts to influence tissue and organ scale behaviours, how natural vari-
ability should be accounted for in generic models, how natural variability
in generic models should inform the credibility of personalised models,
and how prior distributions of model parameters can be constructed to
represent natural variability. Methods developed for geostatistics may be
promising tools to identify and take account of spatial correlations among
model parameters in cardiac tissue [111].
• Cohort modelling of variability within populations is important for
in-silico clinical trials where a model is used to simulate an intervention
on a range of patients [5]. Methods and techniques developed for UQ will
be relevant for this type of application, but progress is at an early stage.
• Quantitative comparison of different sources of uncertainty and
variability at different scales has yet to be undertaken in a systematic
way. The present manuscript has highlighted potential sources of uncer-
tainty, and the next step is to assess their relative importance quantita-
tively. This open question will highlight important sources of uncertainty,
and will motivate efforts to reduce them. A particular example would
be the way that credibility of a personalised model is informed by better
understanding of sources in uncertainty in generic tissue models.
• Coupling of uncertainties across scales requires tools to couple un-
certainties across scales and types of model [92, 116]. This coupling may
operate not only from cell to whole organ, but also in the reverse direction.
Co-variances among model parameters, especially at different scales, are
also an important consideration. A recent study has reviewed sensitivity
analysis in many different modelling applications, and has highlighted the
fact that many sensitivity analyses are flawed because model input spaces
have not been explored thoroughly taking into account co-varying inputs
[122].
Cardiac electrophysiology models have become a valuable tool not only for
basic science, but also have been proposed for transition into clinical applica-
tions [98, 99, 117, 118]. The credibility of model outputs has therefore become
an important challenge. Models are necessarily incomplete representations of
reality, and so uncertainty and sensitivity analysis should focus on quantifying
the extent to which the model outputs are reliable, and the minimisation of
uncertainty [122]. For safety-critical applications, these are crucial questions.
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The main recommendation from the present analysis is therefore that taking
into account uncertainty and variability should be considered a critical aspect of
cardiac electrophysiology model development and evaluation. This is a partic-
ularly important consideration for models that are to be used in safety-critical
applications, where there is a need to assess robustness of outputs, and sensitiv-
ity to clinically meaningful biomarkers. Examples of good practice are beginning
to emerge, where the robustness of a predictive model to uncertainties in the
anatomical mesh and electrophysiology have been assessed [114, 115]. Never-
theless there is an urgent need for end-to-end UQ frameworks that include tools
for model calibration, data assimilation, uncertainty propagation using both
intrusive and non-intrusive methods, as well as certification and validation.
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